BackgroundCheck.run
Search For

Libing Chen, 3945 Keystone Ave, Paoli, PA 19301

Related to:
Bin Chen Hao Chen 46 Xiang A Chen 37 Xue Qun Zou 48

Libing Chen Phones & Addresses

Philadelphia, PA   

Paoli, PA   

Brooklyn, NY   

Derwood, MD   

529 80Th St APT 2, Brooklyn, NY 11209   

Get Report
Control this profile

Mentions for Libing Chen

Libing Chen resumes & CV records

Resumes

Libing Chen Photo 11

Libing Chen

Location:
Philadelphia, PA
Work:
Imclone Systems, A Wholly-Owned Subsidiary of Eli Lilly and Company
Qc Scientist Nextrans
Associate Scientist Phyton Biotech
Senior Research Scientist
Education:
Capital University of Medical Sciences
Libing Chen Photo 12

Libing Chen

Location:
1432 Heather Ridge Dr, Newtown, PA 18940
Industry:
Pharmaceuticals
Skills:
Drug Discovery, Hplc, Organic Chemistry, Drug Design
Languages:
Mandarin
Libing Chen Photo 13

Research Scientist

Location:
Philadelphia, PA
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Research Scientist
Libing Chen Photo 14

Research Scientist At Bms

Position:
research scientist at BMS
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
BMS
research scientist
Libing Chen Photo 15

Qc Scientist At Imclone System

Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Libing Chen Photo 16

Libing Chen

Publications & IP owners

Us Patents

Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors

US Patent:
8252795, Aug 28, 2012
Filed:
Oct 8, 2009
Appl. No.:
12/575589
Inventors:
Brian E. Fink - Yardley PA, US
Libing Chen - Newtown PA, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
Liqi He - Furlong PA, US
Soong-Hoon Kim - Titusville NJ, US
Andrew James Nation - Scotch Plains NJ, US
Yufen Zhao - Pennington NJ, US
Litai H. Zhang - Lawrenceville NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A01N 43/58
A61K 31/50
C07D 487/00
US Classification:
514250, 544236
Abstract:
The invention provides compounds of Formula (I).

Substituted Imidazopyridazines Useful As Kinase Inhibitors

US Patent:
8389527, Mar 5, 2013
Filed:
Feb 6, 2009
Appl. No.:
12/866365
Inventors:
Brian E. Fink - Yardley PA, US
Soong-Hoon Kim - Titusville NJ, US
Yufen Zhao - Pennington NJ, US
Ping Chen - Franklin Park NJ, US
Wayne Vaccaro - Yardley PA, US
Litai Zhang - Lawrenceville NJ, US
Ashvinikumar V Gavai - Princeton Junction NJ, US
Dharmpal S Dodd - Princeton NJ, US
Libing Chen - Newtown PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A01N 43/58
A01N 43/60
C61K 31/50
C07D 487/00
US Classification:
514250, 544236
Abstract:
The invention provides compounds of formula I.

Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors

US Patent:
2012028, Nov 8, 2012
Filed:
Jul 19, 2012
Appl. No.:
13/552795
Inventors:
Brian E. Fink - Yardley PA, US
Libing Chen - Newtown PA, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
Liqi He - Furlong PA, US
Soong-Hoon Kim - Titusville NJ, US
Andrew James Nation - Scotch Plains NJ, US
Yufen Zhao - Pennington NJ, US
Litai H. Zhang - Lawrenceville NJ, US
International Classification:
A61K 31/5025
A61P 35/00
A61P 17/06
A61K 31/538
A61P 35/02
A61K 31/5377
C07D 498/04
C07D 487/04
A61P 29/00
US Classification:
51421021, 544236, 514248, 544117, 5142332, 544105, 5142305
Abstract:
The invention provides compounds of Formula (I)and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.

Ido Inhibitors

US Patent:
2016020, Jul 14, 2016
Filed:
Aug 26, 2014
Appl. No.:
14/914184
Inventors:
- Princeton NJ, US
Steven P. Seitz - Swarthmore PA, US
James Aaron Balog - Lambertville NJ, US
Audris Huang - New Hope PA, US
Sunil Kumar Mandal - Bangalore, Karnataka, IN
Shefali Srivastava - Jaipur, Rajasthan, IN
David K. Williams - Delran NJ, US
Libing Chen - Newtown PA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07C 275/42
A61K 31/41
A61K 45/06
C07C 311/09
A61K 31/18
A61K 31/17
C07D 417/12
A61K 31/427
C07D 333/38
A61K 31/381
C07D 401/10
A61K 31/4439
C07D 407/12
C07D 211/14
A61K 31/451
C07D 403/12
A61K 31/506
C07D 413/12
A61K 31/422
A61K 31/497
A61K 31/4709
C07D 237/20
A61K 31/50
A61K 31/5375
C07D 257/04
Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.

Imidazotriazinecarbonitriles Useful As Kinase Inhibitors

US Patent:
2016010, Apr 21, 2016
Filed:
Dec 21, 2015
Appl. No.:
14/976476
Inventors:
- Princeton NJ, US
Brian E. Fink - Yardley PA, US
Walter Lewis Johnson - Waterbury CT, US
Amy C. Hart - Ewing NJ, US
Liqi He - Furlong PA, US
Tram N. Huynh - Pennington NJ, US
Harold Mastalerz - Guilford CT, US
Xiaopeng Sang - Glastonbury CT, US
Christine M. Tarby - Lawrenceville NJ, US
Honghe Wan - Pennington NJ, US
Wayne Vaccaro - Yardley PA, US
Guifen Zhang - Wallingford CT, US
Yufen Zhao - Pennington NJ, US
Kurt Zimmermann - Durham CT, US
Yong Zhang - Princeton Junction NJ, US
Libing Chen - Newtown PA, US
Bin Chen - Pennington NJ, US
John S. Tokarski - Princeton NJ, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
International Classification:
C07D 487/04
C07F 9/6561
C07F 7/18
C07D 519/00
Abstract:
The invention provides compounds of Formula (I)and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.

Inhibitors Of Indoleamine 2,3-Dioxygenase (Ido)

US Patent:
2016002, Jan 28, 2016
Filed:
Mar 12, 2014
Appl. No.:
14/776035
Inventors:
- Princeton NJ, US
Audris Huang - New Hope PA, US
Bin Chen - Lambertville NJ, US
Libing Chen - Newtown PA, US
Steven P. Seitz - Swarthmore PA, US
Amy C. Hart - Ewing NJ, US
Jay A. Markwalder - Lahaska PA, US
International Classification:
A61K 31/196
A61K 31/505
A61K 31/44
A61K 31/41
A61K 31/4245
A61K 31/42
A61K 31/36
A61K 31/27
A61K 31/216
A61K 31/18
C07D 239/42
C07D 241/42
C07D 213/84
C07D 213/75
C07D 271/12
C07D 261/14
C07D 257/04
C07D 317/66
C07C 271/28
C07C 69/743
C07C 275/42
C07C 311/47
A61K 45/06
C07C 233/55
A61N 5/10
A61K 31/498
Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Imidazotriazinecarbonitriles Useful As Kinase Inhibitors

US Patent:
2015021, Jul 30, 2015
Filed:
Jul 12, 2013
Appl. No.:
14/414152
Inventors:
- Princeton NJ, US
Brian E. Fink - Yardley PA, US
Walter Lewis Johnson - Waterbury CT, US
Amy C. Hart - Ewing NJ, US
Liqi He - Furlong PA, US
Tram N. Huynh - Pennington NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Harold Mastalerz - Guilford CT, US
Xiaopeng Sang - Glastonbury CT, US
Christine M. Tarby - Lawrenceville NJ, US
Honghe Wan - Pennington NJ, US
Wayne Vaccaro - Yardley PA, US
Guifen Zhang - Wallingford CT, US
Yufen Zhao - Pennington NJ, US
Kurt Zimmermann - Durham CT, US
Yong Zhang - Princeton Junction NJ, US
Libing Chen - Newtown PA, US
Bin Chen - Pennington NJ, US
John S. Tokarski - Princeton NJ, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
International Classification:
C07D 487/04
C07F 7/18
C07D 487/10
C07D 487/08
C07D 471/10
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.

Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors

US Patent:
2014017, Jun 26, 2014
Filed:
Feb 27, 2014
Appl. No.:
14/191861
Inventors:
- Princeton NJ, US
Libing Chen - Newtown PA, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
Liqi He - Furlong PA, US
Soong-Hoon Kim - Titusville NJ, US
Andrew James Nation - Scotch Plains NJ, US
Yufen Zhao - Pennington NJ, US
Litai H. Zhang - Lawrenceville NJ, US
International Classification:
C07D 487/04
C07D 498/04
US Classification:
51421021, 514248, 5142332, 5142305
Abstract:
The invention provides compounds of Formula (I)and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.

Isbn (Books And Publications)

Cun Jing Ji Fa Zhan

Author:
Libing Chen
ISBN #:
7307047349

Possible Relatives

Cynthia Chen  David Chen  Cyril X Chen  Cyrus Y Chen  Dawei W Chen  De T Chen  Dafang Chen 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.